Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Palatin Technologies Inc. (PTN)

  • Technical Exchange News
  • May 08, 2025, 00:31 UTC
  • 7

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Palatin Technologies, Inc. Common Stock.

Comment Full text

Sangamo Therapeutics Inc (SGMO)

  • Technical Exchange News
  • May 07, 2025, 19:23 UTC
  • 7

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

PLURI (PLUR)

  • Technical Exchange News
  • May 07, 2025, 19:22 UTC
  • 7

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Palisade Bio Inc. (PALI)

  • Technical Exchange News
  • May 07, 2025, 19:22 UTC
  • 7

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Hyperfine Inc (HYPR)

  • Technical Exchange News
  • May 07, 2025, 19:22 UTC
  • 7

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Estrella Immunopharma Inc. (ESLA)

  • Technical Exchange News
  • May 07, 2025, 19:22 UTC
  • 7

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Seres Therapeutics Inc (MCRB)

  • Technical Exchange News
  • May 07, 2025, 01:53 UTC
  • 10

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Eyenovia Inc. (EYEN)

  • Technical Exchange News
  • May 07, 2025, 01:53 UTC
  • 9

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Seres Therapeutics Inc (MCRB)

  • Technical Exchange News
  • May 06, 2025, 19:18 UTC
  • 9

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Eyenovia Inc. (EYEN)

  • Technical Exchange News
  • May 06, 2025, 19:18 UTC
  • 9

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 28
  • 29
  • 30
  • 31
  • 32
  • Next

Search

News categories

  • Technical Exchange News(9311)
  • Event(407)
  • SEC News(150513)
  • FDA Approval(8583)
  • Company Report(721)
  • Business News(103446)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin